The Conclave at Amalthea aims to spread ideas and wisdom. It acts as a platform for organising discourse on various techno-managerial ﬁelds and foster innovation, inquisition and creativity among the masses.
The Conclave will host speakers, visionaries and leaders who with the experience they have spread knowledge, and provide great insight into problems and their creative solutions. The talks shall be under the umbrella of this year's theme "Transcending Boundaries". They will focus on the exponential growth and development we have seen in technology and its applications in the last few decades.
Director, Data Sciences
Dentsu Aegis Network
Forbes 30 under 30 | 2019
Topic: "Evolution of Communication"
19th October | 4pm - 5pm
Dr S Christopher
Former Chairman, DRDO
Former Director, Centre for Airborne Systems
20th October | 2pm - 3pm
Dr Tapan Misra
Sr. Adivsor to Chairman ISRO
Former Director of SAC, ISRO
20th October | 4pm - 5pm
Former Executive Director RBI
Board of Directors BHIM
Topic : "Fintech and it's regulation"
20th October | 11:45pm - 12:45pm
CEO, Incore Semiconductors
Technical Lead, SHAKTI
Topic: "Lowering Barriers of Innovation - Open Source"
19th October | 2pm - 3pm
British Deputy High Commissioner
Topic: "Cross Country Intellectual Collaboration"
20th October | 10:00am - 11:00am
SUBSCRIBE FOR UPDATES
Be the first to find out about all the major announcements and breaking news from Amalthea '19. We will update you at the earliest.
"The strength of the team is each individual member. The strength of each member is the team."
With this in the mind, Amalthea comes back this year with a brand new iteration of "BRAINWIZ", an event specifically for students of class 8th to 12th to encourage them to look beyond their textual knowledge and give them a break from their traditional classroom learning.
It is an event aimed at testing the participants' logical aptitude and applicative knowledge of science and maths. The event consists of three rounds - logical aptitude tests, chosen genre and buzzer round each with a surprise sub round.
While being challenging to play against the best, it will also be a great fun. So gear up, don't question your strength, find a group of people who challenge and inspire you and get ready for the title of ‘BRAINWIZ’ and win exciting prizes. Stay glued to the website for updates.
Sachin Dubey is the head of “Formulation and Analytical Development” at Glenmark Pharmaceuticals SA. He specialises in areas of biopharmaceuticals, biomaterial and pharmaceutical device engineering having a balanced experience of academia and industry with persistent interest in contributing towards basic research. He completed his M. Tech. (Pharm.) Pharmaceutical Technology (Biotechnology) in 2006 from National Institute of Pharmaceutical Education and Research (NIPER). He received the prestigious “Chairman Excellence Award” for best innovation team in 2018 along with the “Association of Pharmacy Professional (APP, India) Young Achiever Award” in 2018. He has numerous patents to his name and has even authored various books. He has successfully applied his extravagant teaching and industrial experience to steer and designing the strategies for drug product and device development for Glenmark’s biologics.
Dr. Srinivas Oruganti
Dr. Srinivas Oruganti is actively engaged in academia-industry collaborations in the pharmaceutical sector in India and has been championing industry-oriented process chemistry programs at the Dr. Reddy’s Institute of Life Sciences in Hyderabad. He has actively contributed to several successful medicinal chemistry collaborations with several pharma and biotech companies, involving hit-to-lead identification and lead optimization (SAR activity and focused libraries) for different therapeutic areas. He has contributed significantly to various aspects of early stage process development of active pharmaceutical ingredients - ranging from therapeutic areas like diabetes, cardio-vascular, multiple sclerosis and cancer. His pivotal contributions pertain to bringing an active pharmaceutical ingredient to market as a generic drug through innovation in chemical process development and offering a strategic vantage point to any pharmaceutical company in its efforts to carve out a niche for itself in ever challenging generic drug market. He has been contributing to promotion of academic-industry linkages to promote the pharmaceutical innovation in the country and is a member of the Think-Tank of PHARMEXCIL-India to reduce API import dependence in the country.